| Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease (NCT03300830) | National Cancer Institute (NCI) | 2017-12-20 |
| Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT (NCT02201420) | Navidea Biopharmaceuticals | 2014-09-01 |
| Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma (NCT02212639) | Assistance Publique - Hôpitaux de Paris | 2014-09-01 |
| A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma (NCT02029430) | ImmunityBio, Inc. | 2014-04-03 |
| Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma (NCT01352117) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-18 |
| Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) (NCT01276236) | University of California, San Francisco | 2011-03-09 |
| 124I-FIAU Imaging in EBV and KSHV Associated Cancers (NCT00982449) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-12-01 |
| Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity (NCT01296815) | Centro de Investigación en. Enfermedades Infecciosas, Mexico | 2010-09-01 |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma (NCT00686842) | AIDS Malignancy Consortium | 2008-09-01 |
| Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma (NCT01067690) | Barbara Ensoli, MD, PhD | 2008-06-01 |
| Anti-Retrovirals for Kaposi's Sarcoma (NCT00444379) | University of California, San Francisco | 2007-04-01 |
| BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma (NCT00287495) | National Cancer Institute (NCI) | 2006-02-02 |
| Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients (NCT00055237) | National Cancer Institute (NCI) | 2003-02-26 |
| HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT (NCT00380770) | University of KwaZulu | 2003-01-01 |
| Risk Factors for Non-HIV-Related Kaposi s Sarcoma (NCT00339326) | National Cancer Institute (NCI) | 2002-09-01 |
| Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions (NCT00026793) | National Cancer Institute (NCI) | 2001-04-23 |
| Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer (NCT00006518) | National Cancer Institute (NCI) | 2000-12-06 |
| Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma (NCT00006171) | National Cancer Institute (NCI) | 2000-08-07 |
| Optical Biopsy of Human Skin in Conjunction With Laser Treatment (NCT00540566) | University of California, Irvine | 1999-06-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers (NCT00001560) | National Cancer Institute (NCI) | 1996-12-24 |
| Twins Study of Gene Therapy for HIV Infection (NCT00001535) | National Human Genome Research Institute (NHGRI) | 1996-03-01 |
| Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens (NCT00001294) | National Cancer Institute (NCI) | 1992-01-01 |